Coronary Artery Disease and Myocardial Infarction

Mohanad Gabani , Michael D Shapiro , Peter P Toth ,

Read time: 18m

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)

John F Beltrame , Peter Ong , Filippo Crea ,

Read time: 18m
ESC 23: LIBerate-HeFH Study

Frederick Raal,

Watch time: 4m 16s
ESC 23 Late-Breaker Discussion: The RECORD MI Registry

Harriette Van Spall, Javed Butler,

Watch time: 9m 37s
ESC 23: The ILUMIEN IV Trial

Ziad A Ali,

Watch time: 4m 12s
ESC 23: OCEAN(a)-DOSE Trial Update

Michelle O'Donoghue,

Watch time: 3m 22s
ESC 23: LODESTAR Trial

Myeong-Ki Hong,

Watch time: 3m 42s

Yan Yan, Gilles Montalescot, Mathieu Kerneis, et al

Watch time: 5h 59m 38s (60 videos)

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)

Kensuke Nishimiya , Jun Takahashi , Kazuma Oyama , et al

Read time: 12m

Marinela Beznă , Gabriela Mitoaica , Lorena Ungureanu , et al

Read time: 1 Min

Sivabaskari Pasupathy , Rosanna Tavella , Simon McRae , et al

Hans-Willi Breuer ,

Remo Albiero ,

Astrid Hubert , Andreas Seitz , Valeria Martínez Pereyra , et al

Kevin Cheng , Paul Sainsbury , Michael Fisher , et al

Yukiko Isekame , Sabiha Gati , Jose Antonio Aragon-Martin , et al

Kausik Ray, , , et al

Watch time: 1h 35m (4 videos)

Alberto Lorenzatti , Peter P Toth ,

Ewa Dembowski , Michael H Davidson ,

Sumanth Khadke , Jovana Vidovic , Vinod Patel ,

Kerry Layne , Albert Ferro ,

Julia Sikorska , James Uprichard ,

Media

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23 Late-Breaker Discussion: The RECORD MI Registry

Harriette Van Spall, Javed Butler,

Watch time: 9m 37s
ESC 23: The ILUMIEN IV Trial

Ziad A Ali,

Watch time: 4m 12s

Yan Yan, Gilles Montalescot, Mathieu Kerneis, et al

Watch time: 5h 59m 38s (60 videos)

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 28s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2m 29s

Yassir Javaid, , , et al

Watch time: 1h 7m 2s (4 videos)

Media

Yassir Javaid, , , et al

Watch time: 1h 7m 2s (4 videos)
ESC 23 Late-Breaker Discussion: The RECORD MI Registry

Harriette Van Spall, Javed Butler,

Watch time: 9m 37s

Yan Yan, Gilles Montalescot, Mathieu Kerneis, et al

Watch time: 5h 59m 38s (60 videos)
ESC 23: OCEAN(a)-DOSE Trial Update

Michelle O'Donoghue,

Watch time: 3m 22s
ESC 23: LODESTAR Trial

Myeong-Ki Hong,

Watch time: 3m 42s
ESC 23: LIBerate-HeFH Study

Frederick Raal,

Watch time: 4m 16s

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: The ILUMIEN IV Trial

Ziad A Ali,

Watch time: 4m 12s

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1h 27m 1s

Lina Badimon, Dominick J Angiolillo, Christopher B Granger, et al

Watch time: 1h 51m 18s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s

Articles

Guest Editorial: Is Cardio-oncology Ready for Algorithms?

Steven M Ewer

,

Citation:

European Cardiology Review 2018;13(1):62–3.

DOI:

https://doi.org/10.15420/ecr.2018.13.1.GE2
  • Views: Views 1035
  • Downloads: Downloads 4

Sphingomyelin and Cardiovascular Implications

Petros Kikas

,

George Chalikias

,

Dimitrios Tziakas

,

Citation:

European Cardiology Review 2018;13(1):42–5.

DOI:

https://doi.org/10.15420/ecr.2017:20:3
  • Views: Views 1006
  • Downloads: Downloads 6
  • Citations: 23

Guest Editorial: Reducing Risk in Familial Hypercholesterolaemia and Severe Dyslipidaemia: Novel Drugs Targeting PCSK9

Antonio J Vallejo-Vaz

,

Citation:

European Cardiology Review 2018;13(1):7–8.

DOI:

https://doi.org/10.15420/ecr.2018.13.1.GE3
  • Views: Views 263
  • Downloads: Downloads 2

Management of Severe Dyslipidaemia: Role of PCSK9 Inhibitors

Stephen J Nicholls

,

Citation:

European Cardiology Review 2018;13(1):9–13.

DOI:

https://doi.org/10.15420/ecr.2018.3.2
  • Views: Views 564
  • Downloads: Downloads 6
  • Citations: 1